[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352717-105":59,"doc-detail-352717-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","gp-perspectives-on-genomics-in-primary-care-a-qualitative-study-on-using-polygenic-risk-scores-to-evaluate-cancer-risk","GP perspectives on genomics in primary care - a qualitative study on using polygenic risk scores to evaluate cancer risk","","A polygenic risk score (PRS) can personalise cancer risk and support risk stratification for melanoma, colorectal, breast, and prostate cancers. The study explores how Australian general practitioners view using PRSs to tailor cancer screening within existing preventative health models. Thirty GPs were interviewed, and thematic analysis identified perceived benefits for communication and lifestyle discussion, alongside barriers including time limits, genomics upskilling needs, psychosocial harms, life-insurance concerns, and system capacity pressures.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gp-perspectives-on-genomics-in-primary-care-a-qualitative-study-on-using-polygenic-risk-scores-to-evaluate-cancer-risk/352717/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gp-perspectives-on-genomics-in-primary-care-a-qualitative-study-on-using-polygenic-risk-scores-to-evaluate-cancer-risk/352717.png","ImageObject",300,407,{"name":92,"@type":93},"Aria Callaghan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of using polygenic risk scores in primary care for cancer?","Question",{"text":112,"@type":113},"The study focuses on using PRSs to tailor cancer screening by helping stratify individual risk, considering factors such as age, sex, family history, and genomic test results.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the qualitative study conducted and analyzed?",{"text":117,"@type":113},"Thirty GPs in Victoria, Australia were interviewed; participants were PRS naive or had research experience. Inductive and deductive thematic analysis was performed using the Consolidated Framework for Implementation Research.",{"name":119,"@type":110,"acceptedAnswer":120},"What barriers did GPs identify when implementing PRS-based testing?",{"text":121,"@type":113},"Reported barriers included time constraints in preventative care delivery, education requirements to upskill GPs in genomics, potential psychosocial harms for higher-risk patients, life-insurance implications, and added pressure on an already strained health system.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352717,1790149311,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962084926284,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Research  \nGP perspectives on genomics in primary care:  \na qualitative study on using polygenic risk scores to evaluate cancer risk  \nGeorgia Ramsay, Rachel Brooks, Christina Wade, Jamie Jie Mei Liew, Pavithran Alphonse, Jennifer McIntosh, Laura E Forrest, Jon Emery and Sibel Saya  \nAbstract  \nBackground  \nA polygenic risk score (PRS) enables personalisation of cancer risk and supporting risk stratification for melanoma, colorectal, breast, and prostate cancers. Including a PRS ina cancer risk assessment can facilitate risk-appropriate cancer screening by incorporating an individual’s age, sex, family history, and genomic test results. GPs are the likely healthcare professionals to order PRS tests and deliver results to patients within existing preventative health models.  \nAim  \nTo elucidate GPs’ perspectives on the use of PRSs to tailor cancer screening in the Australian primary care context.  \nDesign & setting  \nA qualitative study undertaken in Victoria, Australia with GPs involved  \nin a series of studies and clinical trials evaluating PRS.  \nMethod  \nThirty GPs were interviewed; they were either PRS naive or had experience of using PRSs in a research context. Participants had a broad spectrum of clinical experience and knowledge of genomics, reflecting the spectrum of experience and knowledge of GPs in Victoria, Australia. Inductive and deductive thematic analysis was conducted and aligned to the Consolidated Framework for Implementation Research.  \nResults  \nCommon themes identified were: general practice is the appropriate setting for PRS-based approaches, personalised approaches to cancer risk can prompt discussions about  \npositive lifestyle changes, and tailored risk reports are useful tools for the communication of complex health information. Barriers identified by GPs included: time constraints on the delivery of preventative health care, education requirements to upskill GPsin genomics, possible psychosocial harms to patients identified as being at increased risk, life-insurance implications, and added pressure on an already struggling health system.  \nConclusion  \nThese findings provide insight into the requirements for the implementation of PRSs in primary care, from the perspective of GPs.  \nKeywords  \ncancer risk; GP perspectives; polygenic risk scores; cancer screening; primary care  \nIntroduction  \nA polygenic risk score (PRS) can predict an individual’s risk of developing a range of chronic conditions, including some cancers. A PRS applies multiple common single nucleotide polymorphisms (SNPs)  \nthat have been identified through genome-wide association studies; each SNP confers a small incremental contribution to an individual’s overall risk of developing a specific disease. PRSs have been developed for a range of diseases including colorectal,1 breast,2 and prostate cancers,3 as well as melanoma,4 and can be  \ncombined with age, sex, and other risk factors to estimate individual risk in absolute terms and relative to the general population. This approach can risk stratify the population to provide risk-based recommendations for screening activities. For those at greater-than-average risk, increased cancer screening activities (for example: more-frequent screening; commencing screening from an earlier age; or utilising more sensitive, but potentially invasive, screening tests) may be recommended. Conversely, for those with belowaverage risk, the starting age for screening might be delayed or screening  \nmight take place less frequently. Such risk-stratified approaches may be more cost effective than current approaches.5,6 The possibility of recommending less screening remains contentious, with clinician7 and public5,8–11 sentiment on its acceptability and feasibility being mixed.  \nThe potential clinical utility of PRS approaches to risk stratification has been demonstrated in breast,12 colorectal,13 and prostate cancers.14 Ongoing large, randomised trials will provide evidence of clinical and cost effect","cbCaijgUZpL2ZfqE","https://ap.wps.com/l/cbCaijgUZpL2ZfqE","pdf",3807984,"English","# Abstract\n## Background\n## Aim\n## Design & setting\n## Method\n## Results\n## Conclusion\n# Keywords\n# Introduction\n# How this fits in","[{\"question\":\"What is the purpose of using polygenic risk scores in primary care for cancer?\",\"answer\":\"The study focuses on using PRSs to tailor cancer screening by helping stratify individual risk, considering factors such as age, sex, family history, and genomic test results.\"},{\"question\":\"How was the qualitative study conducted and analyzed?\",\"answer\":\"Thirty GPs in Victoria, Australia were interviewed; participants were PRS naive or had research experience. Inductive and deductive thematic analysis was performed using the Consolidated Framework for Implementation Research.\"},{\"question\":\"What barriers did GPs identify when implementing PRS-based testing?\",\"answer\":\"Reported barriers included time constraints in preventative care delivery, education requirements to upskill GPs in genomics, potential psychosocial harms for higher-risk patients, life-insurance implications, and added pressure on an already strained health system.\"}]","GP perspectives on genomics in primary care - a qualitative study on using polygenic risk scores to evaluate cancer risk | PDF",1790101105,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2238a1f6bbd16b4bd5070ad4da32e86d.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc52c6ccbb81d55204dd46781fd26b76.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45c00065803018f1f7d5e8dc4cb17a4e.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1a78fa95bdd2e9f44d013b6dd4e81371.webp",980,1385]